Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? (Nature Reviews Urology, (2020), 17, 9, (491-492), 10.1038/s41585-020-0357-1)

Shilpa Gupta, Ashish M. Kamat

Research output: Contribution to journalComment/debatepeer-review

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original languageEnglish (US)
Pages (from-to)540
Number of pages1
JournalNature Reviews Urology
Volume17
Issue number9
DOIs
StatePublished - Sep 1 2020

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? (Nature Reviews Urology, (2020), 17, 9, (491-492), 10.1038/s41585-020-0357-1)'. Together they form a unique fingerprint.

Cite this